Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: A case-controlled study
- 1 January 1993
- journal article
- Published by Wiley in Journal of Medical Virology
- Vol. 41 (S1) , 118-122
- https://doi.org/10.1002/jmv.1890410523
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- SYMPTOMATIC CYTOMEGALOVIRUS DISEASE IN THE CYTOMEGALOVIRUS ANTIBODY SEROPOSITIVE RENAL TRANSPLANT RECIPIENT TREATED WITH OKT31,2Transplantation, 1992
- Effect of Towne Live Virus Vaccine on Cytomegalovirus Disease after Renal TransplantAnnals of Internal Medicine, 1991
- Options for Prevention of Cytomegalovirus DiseaseAnnals of Internal Medicine, 1991
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989
- ONE-MONTH PROPHYLACTIC USE OF OKT3 IN CADAVER KIDNEY TRANSPLANT RECIPIENTSTransplantation, 1988
- Treatment of Serious Cytomegalovirus Infections with 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine in Patients with AIDS and Other ImmunodeficienciesNew England Journal of Medicine, 1986
- RECOMBINANT LEUCOCYTE INTERFERON A INDUCES STEROID-RESISTANT ACUTE VASCULAR REJECTION EPISODES IN RENAL TRANSPLANT RECIPIENTSThe Lancet, 1984
- Effects of Interferon-Alpha on Cytomegalovirus Reactivation Syndromes in Renal-Transplant RecipientsNew England Journal of Medicine, 1983
- Cytomegalovirus Disease: Can it be Prevented?Annals of Internal Medicine, 1983
- Cytomegalovirus Disease in Renal Allograft RecipientsMedicine, 1980